TABLE 4.
Outcomes of 132 patients with Pseudomonas aeruginosa bloodstream infection compared by treatment groups
| Endpointsa | Total n = 132 (%) | Cases n = 44 (%) | Controls n = 88 (%) | P value |
|---|---|---|---|---|
| Primary endpoint | ||||
| Seven-day case fatality rate | 32 (24.2) | 3 (6.8) | 29 (34.1) | 0.001 |
| Thirty-day case fatality rate | 53 (40.2) | 10 (22.7) | 43 (48.9) | 0.005 |
| Secondary endpoints | ||||
| Persistent BSI | 22 (17.1) | 4 (9.1) | 18 (21.2) | 0.084 |
| ICU admissionb | 46 (34.8) | 12 (27.3) | 34 (38.6) | 0.246 |
| Need for invasive mechanical ventilationb | 35 (26.7) | 6 (13.6) | 29 (33.3) | 0.021 |
| Other | ||||
| Nephrotoxicity | 33 (27.9) | 8 (18.2) | 25 (32.9) | 0.082 |
a
BSI, bloodstream infection; ICU, intensive care unit.
b
None of the patients were in the ICU at BSI onset.